These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12859413)

  • 1. UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.
    Fertrin KY; Melo MB; Assis AM; Saad ST; Costa FF
    Clin Genet; 2003 Aug; 64(2):160-2. PubMed ID: 12859413
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
    Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism.
    Martins R; Morais A; Dias A; Soares I; Rolão C; Ducla-Soares JL; Braga L; Seixas T; Nunes B; Olim G; Romão L; Lavinha J; Faustino P
    J Hum Genet; 2008; 53(6):524-528. PubMed ID: 18392554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.
    Heeney MM; Howard TA; Zimmerman SA; Ware RE
    J Lab Clin Med; 2003 Apr; 141(4):279-82. PubMed ID: 12677174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.
    Chaar V; Kéclard L; Etienne-Julan M; Diara JP; Elion J; Krishnamoorthy R; Romana M
    Am J Hematol; 2006 May; 81(5):377-9. PubMed ID: 16628735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.
    Vasavda N; Menzel S; Kondaveeti S; Maytham E; Awogbade M; Bannister S; Cunningham J; Eichholz A; Daniel Y; Okpala I; Fulford T; Thein SL
    Br J Haematol; 2007 Jul; 138(2):263-70. PubMed ID: 17593033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
    de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
    Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
    AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
    PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.
    Hamad Z; Aljedai A; Halwani R; AlSultan A
    Ann Saudi Med; 2013; 33(4):372-6. PubMed ID: 24060717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
    Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
    Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
    Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
    Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
    Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.
    Chaouch L; Talbi E; Moumni I; Ben Chaabene A; Kalai M; Chaouachi D; Mallouli F; Ghanem A; Abbes S
    Dis Markers; 2013; 35(2):67-72. PubMed ID: 24167350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
    Milton JN; Sebastiani P; Solovieff N; Hartley SW; Bhatnagar P; Arking DE; Dworkis DA; Casella JF; Barron-Casella E; Bean CJ; Hooper WC; DeBaun MR; Garrett ME; Soldano K; Telen MJ; Ashley-Koch A; Gladwin MT; Baldwin CT; Steinberg MH; Klings ES
    PLoS One; 2012; 7(4):e34741. PubMed ID: 22558097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars.
    Marinković N; Pasalić D; Grsković B; Ferencak G; Honović L; Rukavina AS
    Coll Antropol; 2008 Sep; 32(3):725-9. PubMed ID: 18982743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease: a multigenic perspective of a single-gene disorder.
    Kutlar A
    Med Princ Pract; 2005; 14 Suppl 1():15-9. PubMed ID: 16103709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of cholelithiasis in sickle cell anemia.
    Heeney MM
    Haematologica; 2005 Feb; 90(2):147. PubMed ID: 15713573
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies.
    Italia KY; Jijina FF; Jain D; Merchant R; Nadkarni AH; Mukherjee M; Ghosh K; Colah RB
    Clin Biochem; 2010 Nov; 43(16-17):1329-32. PubMed ID: 20709051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?
    Grant DJ; Bell DA
    Mol Carcinog; 2000 Dec; 29(4):198-204. PubMed ID: 11170257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in the promoter region of the bilirubin UDP-glucuronosyltransferase (Gilbert's syndrome) in healthy Dutch subjects.
    Te Morsche RH; Zusterzeel PL; Raijmakers MT; Roes EM; Steegers EA; Peters WH
    Hepatology; 2001 Mar; 33(3):765. PubMed ID: 11230763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.